The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes Opioid Recover and Treatment for Patients and Communities Act of 2018.

The request for information asks whether there should be exceptions to the requirement and under what circumstances, and whether CMS should impose penalties for noncompliance. Comments are due Oct. 3.

Related News Articles

Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
An AHA analysis released Sept. 10 highlights how tax-exempt hospitals provided nearly $150 billion in total benefits to their communities in 2022, the most…
Blog
Public
The Paragon Health Institute has published a series of new reports once again alleging large-scale “fraud” in health care. This time their target is enrollment…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…
Headline
A report from AARP and the National Alliance for Caregiving released today found nearly 1 in 4 U.S. adults (63 million) are caring for an adult or child…